Which of the following statements about the tuberculin skin test is correct?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

The Tuberculin Skin Test Has High Sensitivity, Not High Specificity

The correct answer is B - the tuberculin skin test has high sensitivity for tuberculosis. The test approaches 100% sensitivity in persons with latent TB infection and normal immune function, but suffers from poor specificity due to cross-reactivity with BCG vaccination and nontuberculous mycobacteria 1.

Test Performance Characteristics

High Sensitivity

The tuberculin skin test demonstrates excellent sensitivity approaching 100% in immunocompetent individuals with latent TB infection 1. This means the test is highly effective at detecting true infection when present, making it valuable for ruling out TB infection when negative.

Poor Specificity

The test has notably low specificity because false-positive reactions commonly occur in two key populations 1:

  • BCG-vaccinated individuals - Tuberculin reactivity from BCG vaccination persists and can be boosted by repeat testing, with no reliable method to distinguish BCG reactions from true infection (though reactions >20mm are unlikely from BCG alone) 1
  • Nontuberculous mycobacteria exposure - Cross-reactivity with environmental mycobacteria produces false-positive results 1

Recent research confirms this pattern, with one large study showing the test had only 76.6% specificity at the optimal 11mm cutoff 2, and another demonstrating that TST results were confounded by BCG vaccination status while newer interferon-gamma tests were not 3.

Performance in Low Prevalence Settings

The tuberculin skin test performs POORLY in low-prevalence populations, not better 1. This is a critical pitfall to understand:

  • In populations with 5-10% TB infection rates (like the general U.S. population), even with 99% specificity, most positive tests will be false-positives due to the low positive predictive value 1
  • In children entering school with 0.1-1% infection prevalence, the problem is even more pronounced 1
  • The positive predictive value is only 3.11% in some settings, while negative predictive value remains excellent at 99.52% 2

This is why targeted testing of high-risk populations is emphasized - the test performs better when pre-test probability is higher 1.

Clinical Implications

The specificity can be improved by increasing the induration size cutoff (e.g., using 15mm instead of 10mm), but this comes at the expense of decreased sensitivity 1. The optimal cutoff of 11mm balances sensitivity (73.7%) and specificity (76.6%) with a Youden index of 0.503 2.

Statement A (high specificity) is incorrect - the test has poor specificity due to cross-reactivity.

Statement C (more useful in low prevalence areas) is incorrect - the test performs worse in low prevalence settings due to poor positive predictive value.

Therefore, only statement B is correct - the tuberculin skin test has high sensitivity for tuberculosis.

Related Questions

What does a 13 mm raised reaction to the Mantoux (Tuberculin) test indicate?
Can a tuberculin skin test (TST) be performed on a patient presenting with a cough?
Can a Tuberculin (TB) skin test be administered simultaneously with a live vaccine?
Does a positive tuberculin skin test (PPD) indicate latent tuberculosis infection?
Can a patient undergo a Tuberculosis (TB) test while having a fever?
In a 175‑lb adult with persistent fatigue, snoring, dry mouth, mild restless‑legs symptoms, an Epworth Sleepiness Scale score of 6, and a polysomnography showing an apnea‑hypopnea index of approximately 1.6 and lowest oxygen saturation of 87%, what is the appropriate management regarding CPAP use, laboratory evaluation, and treatment of restless‑legs syndrome?
In a 22-year-old woman at 14 weeks gestation with a bicuspid aortic valve, what cardiac assessments and monitoring are indicated?
In a 48-year-old man with high-risk multiple myeloma (osteolytic lesions, anemia, renal impairment, del(17p)) who has only a partial response after three cycles of bortezomib‑lenalidomide‑dexamethasone, what is the appropriate next step in management?
In a 20-year-old female with no prior psychiatric medication, a history of cutting, suicidal ideation, a recent suicide attempt by ingesting 15 acetaminophen tablets, and a history of binge‑eating, purging, and alcohol use, what medication should be initiated?
Will tranexamic acid be beneficial for a dengue patient with severe thrombocytopenia (platelet count around 10 × 10⁹/L)?
Is selatogrel (intravenous P2Y12 antagonist) approved for clinical use, and what are the initial results on its platelet P2Y12 inhibition?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.